Hemostasis and thrombosis (29)
All Items
-
No bleeding during a dialysis catheter insertion in a patient with INR 3.2 due to acute liver dysfunction
-
FAR-BENE Study: pharmacoeconomics and well-being in hemophilia. Monitoring outcomes in light of pharmaceutical expenditure with focus on patients undergoing therapeutic switch
-
Turoctocog alfa pegol versus recombinant factor VIII-Fc fusion protein: a head-to-head pharmacokinetics comparison
-
Early fibrinogen replacement based on shock index and lactate levels in massive postpartum hemorrhage: a retrospective cohort study
-
Response to comments on inclusion of cryoprecipitate, pathogen-reduced on the WHO model lists of essential medicines for adults and children: a call for action
-
Cryoprecipitate should not be the essential medicine recommended by the WHO to treat haemophilia
-
Recommending defunct therapies is a safety risk for hemophilia
-
Direct oral anticoagulants measurement: when is it necessary?
-
Evaluation of platelet function by Total Thrombus-Formation Analysis System (T-TAS®01) in term and preterm infants and its relationship with patent ductus arteriosus. A prospective observational pilot study
-
Navigating anemia and anticoagulation in elderly patients undergoing orthopedic surgery: strategies for preventing complications and implementing treatments
-
Natural history of anti-PF4 antibodies in patients with vaccine-induced immune thrombocytopenia and thrombosis
-
Evaluation of an automated platelet aggregation method for detection of congenital or acquired platelet function defects
-
T-TAS® 01 as a new tool for the evaluation of hemostasis in thrombocytopenic patients after platelet transfusion
-
Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology
-
Global hemostasis assays in acute myeloid leukemia: results of an observational prospective study
-
Hormones and thrombosis: the dark side of the moon
-
Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura
-
Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding
-
Flow-chamber device (T-TAS) to diagnose patients suspected of platelet function defects
-
Bioequivalence of recombinant factor VIII products: a position paper from the Italian Association of Hemophilia Centers
-
Viscoelastic coagulation testing in Neonatal Intensive Care Units: advantages and pitfalls in clinical practice
-
A multicenter, real-world experience with recombinant FXIII for the treatment of patients with FXIII deficiency: from pharmacokinetics to clinical practice. The Italian FXIII Study
-
Thrombosis and bleeding after COVID-19 vaccination: do differences in sex matter?
-
Validation of PLASMIC score in a cohort of patients with suspected thrombotic microangiopathy in an academic medical centre
-
The effect of exosomes released from apheresis platelet concentrates under the impact of gamma irradiation and storage time upon platelet aggregation and hemostasis
29 Items